Mina Tadrous

Assistant Professor, Leslie Dan Faculty of Pharmacy

University of Toronto

Mina is an assistant professor at the Leslie Dan Faculty of Pharmacy at the University of He is also a Scientist, investigator with the Ontario Drug Policy Research Network (ODPRN) and ICES adjunct scientist. He completed a PhD in pharmacoepidemiology at the University of Toronto and previously completed a Masters in Health Outcomes and Policy Research at the University of Tennessee, and a Doctor of Pharmacy at Albany College of Pharmacy. He also completed a pharmacy residency in Drug Information and Health Outcomes at the University of Tennessee and St. Jude Children’s Research Hospital. Mina leads research focused on evaluating drug policies and post-marketing surveillance of medications. He works closely with policymakers and uses large data sets to answer questions about medication real-world safety and effectiveness and improving the optimal use of medications.


All Sessions by Mina Tadrous

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

3:00 pm

3:00 pm

PANEL DISCUSSION: DRUGS FOR RARE DISEASES

Critical Elements for a National Strategy and Framework

With Health Canada preparing for the development and implementation of a national strategy for high-cost drugs for rare diseases, what can we learn from the COVID-19 vaccine journey? Leverage the experience of these market leaders to inform your market access strategy. Establish your game plan by:

  • Determining the types of partnerships and funding that will be key to the successful development of drugs for rare diseases
  • Analyzing the impact of recently increased government funding on the overall treatment pipeline
  • Visualizing potential safe and expeditious routes to commercialization for these medicines 

Chart a course to succeed in the new market access model for rare disease therapies

Agenda: Day 2 Oct 6, 2020